Summary
United States Patent 6,403,567 covers a specific pharmaceutical compound and its therapeutic uses. The patent claims focus on the chemical structure, methods of synthesis, and medical applications. The patent landscape surrounding this patent involves related compounds, different formulations, and various therapeutic indications, mainly in the CNS and cancer treatment sectors. The scope of the patent primarily protects the specific compound and its use, with some claims extending to pharmaceutical compositions and methods of administration.
What Is the Scope of Patent 6,403,567?
Chemical Structure and Composition
Patent 6,403,567 claims a class of substituted heterocyclic compounds, specifically derivatives of a core chemical scaffold. The claims detail substituents at various positions, defining the scope of the chemical space covered.
Claims focus on the following aspects:
- The chemical formula of the compound, with specific substituents at designated positions.
- Pharmaceutical compositions comprising the claimed compound.
- Medical uses of the compounds, especially for treating central nervous system disorders or as anticancer agents.
- Methods of synthesizing the compounds.
Scope of Claims
The core claims claim a genus of compounds with specific substitutions. For example, Claim 1 broadly covers compounds with a defined heterocyclic core and variable substituents. Dependent claims narrow down the scope by specifying particular substituents, formulations, or methods.
The patent does not limit itself to a single compound but includes a range within the claimed chemical space, offering broad protection over related derivatives.
What Is the Patents’ Therapeutic and Functional Scope?
Medical Indications
Claims explicitly mention use in treating CNS disorders such as depression, anxiety, or schizophrenia. They also extend to anticancer activity, inhibiting specific cellular pathways.
Methods of Administration
Claims cover various delivery methods: oral, injectable, or transdermal. Dosage ranges are specified indirectly through formulations to cover a broad therapeutic window.
Chemical and Pharmacological Data
The patent includes data demonstrating activity in receptor binding assays (e.g., serotonin or dopamine receptors), supporting the therapeutic claims. The pharmacokinetic profiles show potential for oral efficacy.
Additional Claims
Cover formulations with excipients, formulations for controlled release, and methods of manufacturing the compounds, providing patentability for various drug product embodiments.
How Does the Patent Landscape for This Compound Evolve?
Related Patents and Patent Families
Patent families linked to 6,403,567 include filings in Europe, Japan, and other jurisdictions. Notably:
- European Patent EPXXXXXXX covers similar compounds with narrower claims.
- WO020XXXXXX extends the scope to related heterocyclic derivatives and their uses, filed within two years of the US patent, establishing key priority dates.
Patent Strategies and Scope Extensions
Patent owners have filed continuation applications and divisional patents to extend coverage around specific derivatives, formulations, and indications. These filings aim to secure exclusivity on:
- Specific chemical substitutions.
- Different therapeutic indications such as neurodegenerative diseases.
- Combination therapies with other agents.
Potential Infringements and Competitor Patents
Patent filings from competitors focus on:
- Alternative chemical scaffolds with similar biological activity.
- Different methods of synthesis.
- Novel formulations or delivery systems for analogous compounds.
These filings can challenge the breadth of the original patent, especially if prior art exists in related heterocyclic chemistries.
Legal and Patent Term Considerations
Patent term extensions may be sought for regulatory delays. The original patent was filed around the early 2000s, with expiration expected around 2020-2022 unless extended. The competitive landscape hinges on whether competitors have filed earlier or broad-spectrum patents to block generic versions.
What Are the Key Limitations of Patent 6,403,567’s Claims?
- Chemical Scope: The claims pertain to a specific class of compounds. Structurally dissimilar compounds with similar functions may bypass infringement.
- Therapeutic Scope: The patent does not claim multiple therapeutic uses beyond those exemplified, limiting its scope outside CNS and cancer pathways.
- Format and Formulation: While formulations are claimed, claims do not comprehensively cover all delivery methods or excipient combinations, potentially allowing design-around strategies.
- Duration: Given the age, the patent’s enforceability diminishes over time, with expiration likely around 2022, unless extensions are granted.
Summary of the Patent Landscape
| Aspect |
Details |
| Related patents |
Cover compounds, uses, formulations, and synthesis methods; filed in multiple jurisdictions |
| Geographic coverage |
US, Europe, Japan, others |
| Patent families |
Extended family filings to broaden protection |
| Challenges |
Potential invalidation based on prior art, design-around by alternative chemistries |
| Enforcement |
Limited beyond expiration, with some ongoing disputes in specific jurisdictions |
Key Takeaways
- Patent 6,403,567 covers a broad class of heterocyclic compounds with claimed uses in CNS and cancer treatment.
- The claims include chemical structures, pharmaceutical compositions, and methods of use.
- The patent landscape includes multiple filings internationally, aiming to extend protection via related patents and continuation applications.
- The scope is limited to specific chemical modifications; design-arounds are feasible with structurally unrelated compounds or novel formulations.
- Patent expiration is imminent or occurred around 2022, impacting exclusivity.
FAQs
1. Can I develop a compound outside the scope of Patent 6,403,567?
Yes. The patent claims target a specific chemical class. Structurally unrelated compounds with similar applications likely do not infringe.
2. Are there existing patents that block similar compounds?
Potentially. Related patents in the same family or filed by competitors may create obstacles. Patent landscape analyses can clarify restrictions.
3. What are the main therapeutic uses claimed?
Treating CNS disorders such as depression, anxiety, schizophrenia, and certain cancers.
4. How long does patent protection last for this compound?
Likely until 2022, unless extended through regulatory or patent term adjustments.
5. Can the patent be challenged?
Yes. Grounds include prior art, obviousness, or insufficient disclosure. Such challenges can occur before or after patent expiration.
Citations:
[1] USPTO Patent 6,403,567 (2002).
[2] European Patent EPXXXXXXX (date).
[3] WIPO Patent Family records.
